• Explore /
  • Poster
  • / A first-in-human phase I trial of AR-12, a PDK-1 inhibitor, in patients with advanced solid tumors.

A first-in-human phase I trial of AR-12, a PDK-1 inhibitor, in patients with advanced solid tumors.

Abstract Poster

Authors

null

Joaquin Mateo

The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Joaquin Mateo , Johann Sebastian De Bono , Ramesh K. Ramanathan , Maryam B. Lustberg , Andrea Zivi , Dawn Basset , Matthew Ng , Anna-Mary Young , Michelle Garrett , Shaun Decordova , Florence I. Raynaud , Timothy Anthony Yap , Alexander A. Zukiwski , Stefan Proniuk , Charles L. Shapiro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics

Sub Track

PI3-Akt-mTOR Pathway

Clinical Trial Registration Number

NCT00978523

Citation

J Clin Oncol 31, 2013 (suppl; abstr 2608)

DOI

10.1200/jco.2013.31.15_suppl.2608

Abstract #

2608

Poster Bd #

10D

Abstract Disclosures

Similar Posters

First Author: Aurelius Gabriel Omlin

First Author: Susanna Varkey Ulahannan

First Author: Dana Backlund Cardin

First Author: Andrew J. Wagner